Capricor, Inc

Award Value
Disease Team Therapy Development - Research: Rachel Smith Allogeneic Cardiac-Derived Stem Cells for Patients Following a Myocardial Infarction $19,782,136
Total:
$19,782,136.00
Icon for xls export